Intermittent docetaxel chemotherapy is feasible for castration-resistant prostate cancer

ISSN： 2049-9450

Source： Molecular and Clinical Oncology, Vol.3, Iss.2, 2015-01, pp. : 303-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy

By Sternberg C. N. Molina A. North S. Mainwaring P. Fizazi K. Hao Y. Rothman M. Gagnon D. D. Kheoh T. Haqq C. M. Cleeland C. de Bono J. S. Scher H. I.

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1017-1025

Oxford University Press

Access to resources Recommend Favorite

Docetaxel in combination with estramustine and prednisolone for castration-resistant prostate cancer

By Kuramoto Tomomi Inagaki Takeshi Fujii Reona Sasaki Yumiko Nishizawa Satoshi Nanpo Yoshihito Matusmura Nagahide Kohjimoto Yasuo Hara Isao

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 890-897

Springer Publishing Company

Access to resources Recommend Favorite

What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?

By Steineck Gunnar Glimelius Bengt

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1589-1592

Informa Healthcare

Access to resources Recommend Favorite

Clinical outcomes by relative docetaxel dose and dose intensity as chemotherapy for Japanese patients with castration-resistant prostate cancer: a retrospective multi-institutional collaborative study

By Kamiya Naoto Suzuki Hiroyoshi Ueda Takeshi Sato Naohide Nakatsu Hiroomi Mikami Kazuo Sato Nobuo Nomura Kazushi Akakura Koichiro Okano Tatsuya Ooki Takemasa Naya Yukio Ota Sho Masai Motoyuki Ichikawa Tomohiko

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 157-164

Springer Publishing Company

Access to resources Recommend Favorite

Reduced-dose docetaxel for castration-resistant prostate cancer has no inferior impact on overall survival in Japanese patients

By Kita Yuki Shimizu Yosuke Inoue Takahiro Kamba Tomomi Yoshimura Koji Ogawa Osamu

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 718-723

Springer Publishing Company

Access to resources Recommend Favorite